Evidence map›Paper›PMID 35484716›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Single-cell RNA Sequencing Identified Novel Nr4a1

Jiaoyi Chen, Xiao Ru Huang, Fuye Yang, Wai Han Yiu, Xueqing Yu, Sydney C W Tang, Hui Yao Lan

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Loss of NR2F6 Protects from Salmonella Typhimurium Infection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. New insights into fibrotic signaling in renal cell carcinoma.Frontiers in cell and developmental biology · 2023
    Review
  14. Single-cell RNA Sequencing Identified Novel Nr4a1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jiaoyi ChenDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, P. R. China.ORCID 0000-0001-5601-9411
Xiao Ru HuangDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, P. R. China.
Fuye YangDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, P. R. China.
Wai Han YiuDivision of Nephrology, Department of Medicine, The University of Hong Kong, Hong Kong, 999077, P. R. China.
Xueqing YuGuangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, 510080, P. R. China.
Sydney C W TangDivision of Nephrology, Department of Medicine, The University of Hong Kong, Hong Kong, 999077, P. R. China.
Hui Yao LanDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, P. R. China.ORCID 0000-0003-4283-9755
Chinese University of Hong Kong · HKGuangdong Academy of Medical Sciences · CN

Funding

Guangdong-Hong Kong-Macao-Joint Labs Program from Guangdong Science and Technology Department 2019B121205005Lui Che Woo Institute of Innovative MedicineResearch Grants Council of Hong Kong 14101121Research Grants Council of Hong Kong 14104019Research Grants Council of Hong Kong 14117418Research Grants Council of Hong Kong C7018-16GResearch Grants Council of Hong Kong R4012-18
6 · The paper itself

Abstract

Previously, this study demonstrates the critical role of myeloid specific TLR4 in macrophage-mediated progressive renal injury in anti-glomerular basement membrane (anti-GBM) crescentic glomerulonephritis (cGN); however, the underlying mechanism remains largely unknown. In this study, single-cell RNA sequencing (scRNA-seq), pseudotime trajectories reconstruction, and motif enrichment analysis are used, and macrophage diversity in anti-GBM cGN under tight regulation of myeloid-TLR4 is uncovered. Most significantly, a myeloid-TLR4 deletion-induced novel reparative macrophage phenotype (Nr4a1

Indexed as

GlomerulonephritisToll-Like Receptor 4Anti-Inflammatory AgentsEosinophil-Derived NeurotoxinGlomerular Basement MembraneHumansLipopolysaccharidesMacrophagesNuclear Receptor Subfamily 4, Group A, Member 1PhenotypeSequence Analysis, RNAAnti-Inflammatory AgentsEosinophil-Derived NeurotoxinLipopolysaccharidesNR4A1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1TLR4 protein, humanToll-Like Receptor 4anti-GBM crescentic glomerulonephritismacrophagesmyeloid-TLR4Nr4a1/Ear2

Identifiers

PMID35484716
PMCPMC9218767
OpenAlexW4225151720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.